Breakthrough CAR-T Therapy in Refractory B-Cell Lymphoma: MIOT International Chennai, India Case Study. hncmc [Internet]. 2025 Jun. 30 [cited 2026 Aug. 16];3(2):106-15. Available from: https://www.hnchmc.uz/jour/article/view/231